Published in Am J Obstet Gynecol on October 01, 2015
Zika virus damages the human placental barrier and presents marked fetal neurotropism. Mem Inst Oswaldo Cruz (2016) 1.40
Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis (2016) 0.84
Correlation of preterm infant illness severity with placental histology. Placenta (2016) 0.77
Risks associated with viral infections during pregnancy. J Clin Invest (2017) 0.75
In vivo T-cell activation by a monoclonal αCD3ε antibody induces preterm labor and birth. Am J Reprod Immunol (2016) 0.75
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. Nat Rev Rheumatol (2017) 0.75
Recent advances in the prevention of preterm birth. F1000Res (2017) 0.75
Maternal plasma soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study. J Matern Fetal Neonatal Med (2017) 0.75
Inflammatory and vascular placental lesions are associated with neonatal amplitude integrated EEG recording in early premature neonates. PLoS One (2017) 0.75
Predicting preeclampsia from a history of preterm birth. PLoS One (2017) 0.75
Placental Lesions in Meconium Aspiration Syndrome. J Pathol Transl Med (2017) 0.75
In Vivo Activation of Invariant Natural Killer T Cells Induces Systemic and Local Alterations in T-Cell Subsets Prior to Preterm Birth. Clin Exp Immunol (2017) 0.75
The Maternal Gut Microbiome During Pregnancy. MCN Am J Matern Child Nurs (2017) 0.75
Prevention of allogeneic fetal rejection by tryptophan catabolism. Science (1998) 9.80
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med (2011) 6.72
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science (2008) 5.76
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5.24
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant (2006) 3.78
Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 3.43
Rejection of the kidney allograft. N Engl J Med (2010) 3.30
A critical role for murine complement regulator crry in fetomaternal tolerance. Science (2000) 3.27
The fetal inflammatory response syndrome. Am J Obstet Gynecol (1998) 3.22
Preterm labor: one syndrome, many causes. Science (2014) 2.61
Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol (1995) 2.54
Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol (1995) 2.52
Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 2.51
Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 2.42
HLA-G and immune tolerance in pregnancy. FASEB J (2005) 2.37
The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 2.36
Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod (2004) 2.35
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol (2001) 2.23
Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol (2006) 2.20
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med (2005) 2.13
Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature (2012) 2.11
School-age outcomes of late preterm infants in New York City. Am J Obstet Gynecol (2012) 2.10
Immunology of the maternal-fetal interface. Annu Rev Immunol (2013) 2.06
Retracted Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol (2006) 2.00
Antibody-mediated organ-allograft rejection. Nat Rev Immunol (2005) 1.99
The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99
Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med (2002) 1.83
Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science (2012) 1.83
Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A (2007) 1.77
CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol (2004) 1.77
Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest (2007) 1.75
Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol (2005) 1.74
The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74
Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol (1997) 1.70
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol (2003) 1.60
Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol (1995) 1.59
Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol (1991) 1.59
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
The role of placental exosomes in reproduction. Am J Reprod Immunol (2010) 1.53
Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol (1997) 1.51
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47
Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol (2008) 1.46
Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol (2006) 1.44
Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study. Pediatrics (2015) 1.43
Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis (2001) 1.42
Outcomes of late preterm birth: who is at risk and for what? Am J Obstet Gynecol (2012) 1.41
Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol (2009) 1.40
Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol (2012) 1.39
Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol (1990) 1.37
A systematic review of severe morbidity in infants born late preterm. Am J Obstet Gynecol (2011) 1.37
Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol (1995) 1.36
Placental pathologic findings in preterm birth. Am J Obstet Gynecol (1991) 1.32
Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim Biophys Acta (2000) 1.32
The complement system in the pathophysiology of pregnancy. Mol Immunol (2006) 1.30
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood (2003) 1.30
The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol (2010) 1.29
Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol (1993) 1.28
Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol (2007) 1.28
Regulatory T cells and their role in pregnancy. Am J Reprod Immunol (2010) 1.27
Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med (2009) 1.24
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation (2009) 1.23
Multiple pathways to allograft rejection. Transplantation (2002) 1.21
Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol (2012) 1.21
Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci (1977) 1.20
Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant (2009) 1.18
ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol (1997) 1.16
Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol (2001) 1.16
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol (2015) 1.16
Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol (2001) 1.15
A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol (1996) 1.14
CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord (2005) 1.13
Functionally important disorders of the placenta, umbilical cord, and fetal membranes. Hum Pathol (1987) 1.12
A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol (2007) 1.12
Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol (2005) 1.11
Inflammatory lesions of the human placenta. III. The histopathology of villitis of unknown aetiology. Placenta (1981) 1.11
Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology (2008) 1.11
Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol (1998) 1.11
Immunological relationship between the mother and the fetus. Int Rev Immunol (2003) 1.10
The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood (2013) 1.10
A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One (2011) 1.10
The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol (2011) 1.10
A lesson in tolerance--maternal instruction to fetal cells. N Engl J Med (2009) 1.09
Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol (2004) 1.08
Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection. Am J Respir Crit Care Med (2003) 1.07
Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol (2005) 1.07
Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol (2013) 1.06
Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol (1985) 1.06
Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol (1992) 1.06